Next Article in Journal
Pandanus amaryllifolius and Tectona grandis Extracts Improve Fetal Outcomes in Streptozotocin-Induced Gestational Diabetes in Rats
Previous Article in Journal
Antimicrobial Properties of Analogs of Dimeric A-Type Proanthocyanidins in Food Matrices
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Jaksic Karisik et al. JQ1 Treatment and miR-21 Silencing Activate Apoptosis of CD44+ Oral Cancer Cells. Int. J. Mol. Sci. 2025, 26, 1241

by
Milica Jaksic Karisik
1,
Milos Lazarevic
1,
Dijana Mitic
1,
Olivera Mitrovic Ajtic
2,
Giuseppe Damante
3 and
Jelena Milasin
1,*
1
Department of Human Genetics, School of Dental Medicine, University of Belgrade, 11000 Belgrade, Serbia
2
Department of Molecular Oncology, Institute for Medical Research, National Institute of the Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia
3
Department of Medical Area, University of Udine, 33100 Udine, Italy
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2026, 27(2), 854; https://doi.org/10.3390/ijms27020854
Submission received: 8 January 2026 / Accepted: 9 January 2026 / Published: 15 January 2026
(This article belongs to the Section Molecular Oncology)

Text Correction

There was an error in the original publication [1]. In the Results section (Section 2.1), the term “magnetic” was mistakenly used in the sentence “Following magnetic sorting, as much as 99.3% were CD44+ cells.” Flow cytometry and the antibodies used do not operate via the principle of magnetic particles; therefore, the redundant terminology should be removed.
Furthermore, the title of Section 4.2 contained an unnecessary prefix “Magnetic,” which should be removed. Additionally, within the same section, the catalog number of the CD44 antibody was incorrect and needs to be updated to the correct reference number (ref. no. 130-133-985). A correction has been made to Results, Section 2.1, Materials and Methods, and Section 4.2, Paragraph 1.
  • 2.1. CD44+ Cell Sorting
CD44+ cells were separated from the heterogenous cancer cell cultures using Fluorescence-Activated Cell Sorting (FACS). In the heterogenous primary cancer cell cultures generated from oral cancer patients, only a small subpopulation (below 1%) of cells were CD44+. Following sorting, as much as 99.3% were CD44+ cells (Figure 1).
  • 4.2. Cell Sorting and Flow Cytometry
CD44+ cell separation was performed using flow cytometry (BD FACS MelodyTM) according to the manufacturer’s protocol. Total populations of adherent cells were enzymatically detached and counted. The cell suspension (106) was incubated with 100 µL of CD44 antibody (ref. no. 130-133-985, Miltenyi Biotec, Auburn, CA, USA) at 4 °C for 30 min; then, cells were washed three times with PBS and passed through the FACS system.

References

The authors would like to remove reference 19 [2] from the manuscript, as it has been retracted. Its removal does not affect the formulation or conclusions. With this correction, the order of some references has been adjusted accordingly.
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

References

  1. Jaksic Karisik, M.; Lazarevic, M.; Mitic, D.; Ajtic, O.M.; Damante, G.; Milasin, J. JQ1 Treatment and miR-21 Silencing Activate Apoptosis of CD44+ Oral Cancer Cells. Int. J. Mol. Sci. 2025, 26, 1241. [Google Scholar] [CrossRef] [PubMed]
  2. Hou, R.; Jiang, L. LINC00115 Promotes Stemness and Inhibits Apoptosis of Ovarian Cancer Stem Cells by Upregulating SOX9 and Inhibiting the Wnt/β-Catenin Pathway through Competitively Binding to microRNA-30a. Cancer Cell Int. 2021, 21, 360. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Jaksic Karisik, M.; Lazarevic, M.; Mitic, D.; Ajtic, O.M.; Damante, G.; Milasin, J. Correction: Jaksic Karisik et al. JQ1 Treatment and miR-21 Silencing Activate Apoptosis of CD44+ Oral Cancer Cells. Int. J. Mol. Sci. 2025, 26, 1241. Int. J. Mol. Sci. 2026, 27, 854. https://doi.org/10.3390/ijms27020854

AMA Style

Jaksic Karisik M, Lazarevic M, Mitic D, Ajtic OM, Damante G, Milasin J. Correction: Jaksic Karisik et al. JQ1 Treatment and miR-21 Silencing Activate Apoptosis of CD44+ Oral Cancer Cells. Int. J. Mol. Sci. 2025, 26, 1241. International Journal of Molecular Sciences. 2026; 27(2):854. https://doi.org/10.3390/ijms27020854

Chicago/Turabian Style

Jaksic Karisik, Milica, Milos Lazarevic, Dijana Mitic, Olivera Mitrovic Ajtic, Giuseppe Damante, and Jelena Milasin. 2026. "Correction: Jaksic Karisik et al. JQ1 Treatment and miR-21 Silencing Activate Apoptosis of CD44+ Oral Cancer Cells. Int. J. Mol. Sci. 2025, 26, 1241" International Journal of Molecular Sciences 27, no. 2: 854. https://doi.org/10.3390/ijms27020854

APA Style

Jaksic Karisik, M., Lazarevic, M., Mitic, D., Ajtic, O. M., Damante, G., & Milasin, J. (2026). Correction: Jaksic Karisik et al. JQ1 Treatment and miR-21 Silencing Activate Apoptosis of CD44+ Oral Cancer Cells. Int. J. Mol. Sci. 2025, 26, 1241. International Journal of Molecular Sciences, 27(2), 854. https://doi.org/10.3390/ijms27020854

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop